School of Life & Medical Sciences, University of Hertfordshire, United Kingdom
Sam Salek is Professor of Pharmacoepidemiology in the School of Life and Medical Sciences, University of Hertfordshire, UK where he leads the Public Health & Patient Safety research group. He is also the Director of the Institute of Medicine Development, Cardiff, UK, a visiting Professor at the State of Hessen, Germany and Vice-President of the PharmaTrain Federation. Professor Salek is the co-founder and the past chair of the Patient Engagement Special Interest Group of the International Society of Quality of Research, co-chairs the European Hematology Association Scientific Working Group for Quality of Life and Symptoms and chairs the EHA SWG ‘Gaucher’s Disease Task Force’.
Professor Salek completed his undergraduate degree at the University of Oklahoma in 1978. He later moved to Cardiff where he studied for his PhD, 1985–1989. Since completing his PhD, Professor Salek has held a number of academic posts on both sides of the Atlantic. His major research interests include: pharmaceutical regulatory science to improve patient access to new medicines; benefit-risk assessment of medicines; development, evaluation and application of instruments to assess patient-reported outcomes and health-related quality of life (HRQoL); and pharmacoeconomics/ health economics. Over the past four decades he has received a number of government and industry research grants for projects in the areas of pharmaceutical regulatory science covering jurisdictions such as Middle East, Far East, Africa, India, South and North America.
Professor Salek has developed a few undergraduate, postgraduate diploma and MSc programmes over the past 35 years which they continue to be successful. Of noteworthy: he developed and modernised the 2-year part-time Postgraduate Course in Pharmaceutical Medicine (Dip Pharm Med) and was the Course Director of the same for 30 years; he is the founder of the MSc in International Pharmaeconomic & Health Economics in 2007 and was the Programme Director of the same until 2015; he is the founder of the Integrated Master of Regulatory Science (an undergraduate programme) which received approval from the University of Hertfordshire Validation Board in April 2017 and commenced in September 2018.
Professor Salek is a fellow of the Royal College of Physicians, the Royal Pharmaceutical Society of Great Britain, European Society of Clinical Pharmacy, Global Fellow of the IFAPP in Medicines Development and member of the Cardiff Medical Society. He is a member of five Editorial boards and has published 19 books and over 650 journal articles and abstracts. He has developed and validated 11 general and disease-specific patient-reported HRQoL measures, a quality decision making tool (QoDoS), a quality outpatient discharge information checklist, whilst also collaborating with the pharmaceutical industry to design HRQoL protocols for clinical trials. Increasingly, Professor Salek is shifting his emphasis towards the practical applications of HRQoL measures in clinical decision-making and policy, quality decision-making and patient engagement in research as partners/collaborators.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).